Consider a typical patient journey: a 52-year-old with a starting weight of 230 pounds, A1c of 6.8 percent (prediabetes range), elevated blood pressure, and persistent fatigue despite multiple diet attempts
In the 24-week study of patients receiving JANUVIA as add-on therapy to insulin (with or without metformin), there were no adverse reactions reported regardless of investigator assessment of causality in 5% of patients and more commonly than in patients given placebo, except for hypoglycemia (see Table 3)
GLP-1 adoption in India is a classic case of market readiness being overestimated
found that intraperitoneal injection of exendin-4 increased the number of BrdU-positive progenitor cells in the subventricular zone (33), indicating that exendin-4 could compensate for the loss of dopaminergic neurons in the PD model by promoting the formation of substantia nigra neurons
At the same time, it seemed like everyonefrom Elon Musk and Serena Williams to my former music teacherwere promoting glucagon-like peptide-1s, or GLP-1s, such as Ozempic and Wegovy, as miracle cures that calm food noise, regulate appetite, and help with weight loss
